We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

On January 13, the technology company announced the development of its first whole-genome sequencing test, xH, using artificial intelligence. This test aims to enhance precision medicine and ...

has announced the development of a whole-genome sequencing test, named xH, aimed at enhancing personalized treatment for hematological cancer patients. According to InvestingPro data, the company ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence applications for precision medicine with a market capitalization of $5.9 billion and impressive revenue growth of 32% ...

In a groundbreaking development, hundreds of newborns have started being tested for over 200 rare genetic conditions as part ...

Plus, these tests make for thoughtful, unique holiday gifts. All you have to do is choose a service, receive a DNA testing kit, send back your genetic material and wait for your results to ...

Discover how a groundbreaking blood test using advanced DNA sequencing techniques is set to revolutionize early cancer ...